Nobel Laureate Richard Roberts On Bringing New England BioLabs To Asia: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Nobel Prize winner Richard Roberts was recently in Asia for Singapore’s Global Young Scientist Summit, and he shared his thoughts about launching a business model that funnels profits into basic research globally and why companies should not be profit focused.
You may also be interested in...
Roche Japan unit Chugai Pharmaceutical Nov. 30 announced a licensing agreement with Tokyo-based new drug discovery firm Biocomber. Chugai will use Biocomber proprietary cell-free protein synthesis technology Puresystem to speed up global antibody drug development
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.